Copyright Reports & Markets. All rights reserved.

Global Bioartificial Liver Therapeutic Technology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Bioartificial Liver Therapeutic Technology
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Bioartificial Liver Therapeutic Technology by Type
    • 1.3.1 Overview: Global Bioartificial Liver Therapeutic Technology Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Bioartificial Liver Therapeutic Technology Consumption Value Market Share by Type in 2022
    • 1.3.3 Molecular Adsorbent Recirculating System (MARS)
    • 1.3.4 Fractionated Plasma Separation And Adsorption System (Prometheus)
    • 1.3.5 Single-Pass Albumin Dialysis (SPAD)
    • 1.3.6 Selective Plasma Filtration Therapy
  • 1.4 Global Bioartificial Liver Therapeutic Technology Market by Application
    • 1.4.1 Overview: Global Bioartificial Liver Therapeutic Technology Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Treatment
    • 1.4.3 R&D
  • 1.5 Global Bioartificial Liver Therapeutic Technology Market Size & Forecast
  • 1.6 Global Bioartificial Liver Therapeutic Technology Market Size and Forecast by Region
    • 1.6.1 Global Bioartificial Liver Therapeutic Technology Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Bioartificial Liver Therapeutic Technology Market Size by Region, (2018-2029)
    • 1.6.3 North America Bioartificial Liver Therapeutic Technology Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Bioartificial Liver Therapeutic Technology Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Bioartificial Liver Therapeutic Technology Market Size and Prospect (2018-2029)
    • 1.6.6 South America Bioartificial Liver Therapeutic Technology Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Bioartificial Liver Therapeutic Technology Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Mayo Clinic
    • 2.1.1 Mayo Clinic Details
    • 2.1.2 Mayo Clinic Major Business
    • 2.1.3 Mayo Clinic Bioartificial Liver Therapeutic Technology Product and Solutions
    • 2.1.4 Mayo Clinic Bioartificial Liver Therapeutic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Mayo Clinic Recent Developments and Future Plans
  • 2.2 WUHAN TOGO MEDITECH CO.,LTD
    • 2.2.1 WUHAN TOGO MEDITECH CO.,LTD Details
    • 2.2.2 WUHAN TOGO MEDITECH CO.,LTD Major Business
    • 2.2.3 WUHAN TOGO MEDITECH CO.,LTD Bioartificial Liver Therapeutic Technology Product and Solutions
    • 2.2.4 WUHAN TOGO MEDITECH CO.,LTD Bioartificial Liver Therapeutic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 WUHAN TOGO MEDITECH CO.,LTD Recent Developments and Future Plans
  • 2.3 Hexaell Biotech Co.,Ltd.
    • 2.3.1 Hexaell Biotech Co.,Ltd. Details
    • 2.3.2 Hexaell Biotech Co.,Ltd. Major Business
    • 2.3.3 Hexaell Biotech Co.,Ltd. Bioartificial Liver Therapeutic Technology Product and Solutions
    • 2.3.4 Hexaell Biotech Co.,Ltd. Bioartificial Liver Therapeutic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Hexaell Biotech Co.,Ltd. Recent Developments and Future Plans
  • 2.4 Guangdong Qianhui Biotechnology Co.,Ltd.
    • 2.4.1 Guangdong Qianhui Biotechnology Co.,Ltd. Details
    • 2.4.2 Guangdong Qianhui Biotechnology Co.,Ltd. Major Business
    • 2.4.3 Guangdong Qianhui Biotechnology Co.,Ltd. Bioartificial Liver Therapeutic Technology Product and Solutions
    • 2.4.4 Guangdong Qianhui Biotechnology Co.,Ltd. Bioartificial Liver Therapeutic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Guangdong Qianhui Biotechnology Co.,Ltd. Recent Developments and Future Plans
  • 2.5 Shanghai CELLIVER Biotechnology Co.,Ltd
    • 2.5.1 Shanghai CELLIVER Biotechnology Co.,Ltd Details
    • 2.5.2 Shanghai CELLIVER Biotechnology Co.,Ltd Major Business
    • 2.5.3 Shanghai CELLIVER Biotechnology Co.,Ltd Bioartificial Liver Therapeutic Technology Product and Solutions
    • 2.5.4 Shanghai CELLIVER Biotechnology Co.,Ltd Bioartificial Liver Therapeutic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Shanghai CELLIVER Biotechnology Co.,Ltd Recent Developments and Future Plans
  • 2.6 Shandong yiruite Biotechnology Co.,Ltd
    • 2.6.1 Shandong yiruite Biotechnology Co.,Ltd Details
    • 2.6.2 Shandong yiruite Biotechnology Co.,Ltd Major Business
    • 2.6.3 Shandong yiruite Biotechnology Co.,Ltd Bioartificial Liver Therapeutic Technology Product and Solutions
    • 2.6.4 Shandong yiruite Biotechnology Co.,Ltd Bioartificial Liver Therapeutic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Shandong yiruite Biotechnology Co.,Ltd Recent Developments and Future Plans
  • 2.7 Guanhao Biotech Co.,Ltd.
    • 2.7.1 Guanhao Biotech Co.,Ltd. Details
    • 2.7.2 Guanhao Biotech Co.,Ltd. Major Business
    • 2.7.3 Guanhao Biotech Co.,Ltd. Bioartificial Liver Therapeutic Technology Product and Solutions
    • 2.7.4 Guanhao Biotech Co.,Ltd. Bioartificial Liver Therapeutic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Guanhao Biotech Co.,Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Bioartificial Liver Therapeutic Technology Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Bioartificial Liver Therapeutic Technology by Company Revenue
    • 3.2.2 Top 3 Bioartificial Liver Therapeutic Technology Players Market Share in 2022
    • 3.2.3 Top 6 Bioartificial Liver Therapeutic Technology Players Market Share in 2022
  • 3.3 Bioartificial Liver Therapeutic Technology Market: Overall Company Footprint Analysis
    • 3.3.1 Bioartificial Liver Therapeutic Technology Market: Region Footprint
    • 3.3.2 Bioartificial Liver Therapeutic Technology Market: Company Product Type Footprint
    • 3.3.3 Bioartificial Liver Therapeutic Technology Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Bioartificial Liver Therapeutic Technology Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Bioartificial Liver Therapeutic Technology Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Bioartificial Liver Therapeutic Technology Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Bioartificial Liver Therapeutic Technology Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Bioartificial Liver Therapeutic Technology Consumption Value by Type (2018-2029)
  • 6.2 North America Bioartificial Liver Therapeutic Technology Consumption Value by Application (2018-2029)
  • 6.3 North America Bioartificial Liver Therapeutic Technology Market Size by Country
    • 6.3.1 North America Bioartificial Liver Therapeutic Technology Consumption Value by Country (2018-2029)
    • 6.3.2 United States Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Bioartificial Liver Therapeutic Technology Consumption Value by Type (2018-2029)
  • 7.2 Europe Bioartificial Liver Therapeutic Technology Consumption Value by Application (2018-2029)
  • 7.3 Europe Bioartificial Liver Therapeutic Technology Market Size by Country
    • 7.3.1 Europe Bioartificial Liver Therapeutic Technology Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 7.3.3 France Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Bioartificial Liver Therapeutic Technology Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Bioartificial Liver Therapeutic Technology Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Bioartificial Liver Therapeutic Technology Market Size by Region
    • 8.3.1 Asia-Pacific Bioartificial Liver Therapeutic Technology Consumption Value by Region (2018-2029)
    • 8.3.2 China Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 8.3.5 India Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Bioartificial Liver Therapeutic Technology Consumption Value by Type (2018-2029)
  • 9.2 South America Bioartificial Liver Therapeutic Technology Consumption Value by Application (2018-2029)
  • 9.3 South America Bioartificial Liver Therapeutic Technology Market Size by Country
    • 9.3.1 South America Bioartificial Liver Therapeutic Technology Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Bioartificial Liver Therapeutic Technology Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Bioartificial Liver Therapeutic Technology Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Bioartificial Liver Therapeutic Technology Market Size by Country
    • 10.3.1 Middle East & Africa Bioartificial Liver Therapeutic Technology Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Bioartificial Liver Therapeutic Technology Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Bioartificial Liver Therapeutic Technology Market Drivers
  • 11.2 Bioartificial Liver Therapeutic Technology Market Restraints
  • 11.3 Bioartificial Liver Therapeutic Technology Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Bioartificial Liver Therapeutic Technology Industry Chain
  • 12.2 Bioartificial Liver Therapeutic Technology Upstream Analysis
  • 12.3 Bioartificial Liver Therapeutic Technology Midstream Analysis
  • 12.4 Bioartificial Liver Therapeutic Technology Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Bioartificial Liver Therapeutic Technology market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Bioartificial liver treatment technology is a kind of extracorporeal blood purification equipment used to replace or support liver function, mainly composed of bioreactor, artificial liver machine, blood pipeline, heater, oxygenator, heparin pump, plasma separator, data Recording and other devices. The treatment method is to export the plasma of patients with liver failure through an artificial liver pipeline, and separate it into blood cells and plasma through a plasma separator; the plasma with toxin enters the improved bioreactor loaded with HL2 cells after oxygenation, and the toxin Through diffusion, the overflow contacts with the hepatocytes in the reactor and is purified; the purified plasma and blood cells are reunited and then reinfused into the patient to complete the treatment cycle.
    This report is a detailed and comprehensive analysis for global Bioartificial Liver Therapeutic Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Bioartificial Liver Therapeutic Technology market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Bioartificial Liver Therapeutic Technology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Bioartificial Liver Therapeutic Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Bioartificial Liver Therapeutic Technology market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Bioartificial Liver Therapeutic Technology
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Bioartificial Liver Therapeutic Technology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mayo Clinic, WUHAN TOGO MEDITECH CO.,LTD, Hexaell Biotech Co.,Ltd., Guangdong Qianhui Biotechnology Co.,Ltd. and Shanghai CELLIVER Biotechnology Co.,Ltd, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Bioartificial Liver Therapeutic Technology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Molecular Adsorbent Recirculating System (MARS)
    Fractionated Plasma Separation And Adsorption System (Prometheus)
    Single-Pass Albumin Dialysis (SPAD)
    Selective Plasma Filtration Therapy
    Market segment by Application
    Treatment
    R&D
    Market segment by players, this report covers
    Mayo Clinic
    WUHAN TOGO MEDITECH CO.,LTD
    Hexaell Biotech Co.,Ltd.
    Guangdong Qianhui Biotechnology Co.,Ltd.
    Shanghai CELLIVER Biotechnology Co.,Ltd
    Shandong yiruite Biotechnology Co.,Ltd
    Guanhao Biotech Co.,Ltd.
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Bioartificial Liver Therapeutic Technology product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Bioartificial Liver Therapeutic Technology, with revenue, gross margin and global market share of Bioartificial Liver Therapeutic Technology from 2018 to 2023.
    Chapter 3, the Bioartificial Liver Therapeutic Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Bioartificial Liver Therapeutic Technology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Bioartificial Liver Therapeutic Technology.
    Chapter 13, to describe Bioartificial Liver Therapeutic Technology research findings and conclusion.

    Buy now